diagnostics test

A clinical trial has been started to evaluate and validate a urine-based point of care (POC) diagnostic from Mologic, aimed at helping cystic fibrosis (CF) patients monitor and manage their condition at home. Read more


The UK is in pole position when it comes to patent filings for antimicrobial point-of-care diagnostics in Europe, according to Landon IP, patent analytics and consulting arm of CPA Global and Marks & Clerk. Read more